Common genetic variation of beta1- and beta2-adrenergic receptor and response to four classes of antihypertensive treatment.
Suonsyrjä
Timo
T
Department of Medicine, University of Helsinki, and Research Program for Molecular Medicine, Biomedicum Helsinki, Helsinki, Finland.
Donner
Kati
K
Hannila-Handelberg
Tuula
T
Fodstad
Heidi
H
Kontula
Kimmo
K
Hiltunen
Timo P
TP
D000483:Alleles; D000959:Antihypertensive Agents / Q000494:pharmacology*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D014644:Genetic Variation; D006720:Homozygote; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D010597:Pharmacogenetics / Q000379:methods*; D010919:Placebos; D011110:Polymorphism, Genetic; D018342:Receptors, Adrenergic, beta-1 / Q000235:genetics*; D018343:Receptors, Adrenergic, beta-2 / Q000235:genetics*
D000959:Antihypertensive Agents; D010919:Placebos; D018342:Receptors, Adrenergic, beta-1; D018343:Receptors, Adrenergic, beta-2